Search research articles
Contact Us
Filters
Showing results (71-80 of 151) with videos related to
Page
of 16
Sort By:
Sarcoma
|
January 22, 2011
UK Guidelines for the Management of Bone Sarcomas
Robert Grimer, Nick Athanasou, Craig Gerrand, et al.
Clinical Sarcoma Research
|
May 6, 2016
UK guidelines for the management of bone sarcomas
Craig Gerrand, Nick Athanasou, Bernadette Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma
Ian Judson, Michelle Scurr, Kate Gardner, et al.
Oncology
|
January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer
Hendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG
Viktor Grünwald, Saskia Litière, Robin Young, et al.
Clinical Sarcoma Research
|
November 28, 2013
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature
Han Hsi Wong, Helen M Hatcher, Charlotte Benson, et al.
Circulation
|
November 7, 2012
Characterization of cardiac sarcoma with 2- and 3-dimensional echocardiography, myocardial contrast echocardiography and cardiac magnetic resonance imaging
Sanjeev Bhattacharyya, Isabelle Roussin, Sanjay Prasad, et al.
Anticancer Research
|
October 28, 2015
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study
Jonathan Noujaim, Khin Thway, Robin L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2008
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?
Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, et al.
Sarcoma
|
July 13, 2016
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas
Joanna Vitfell-Rasmussen, Ian Judson, Akmal Safwat, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 151) with videos related to
Sort By:
Page
of 16
Sarcoma
|
January 22, 2011
UK Guidelines for the Management of Bone Sarcomas
Robert Grimer, Nick Athanasou, Craig Gerrand, et al.
Clinical Sarcoma Research
|
May 6, 2016
UK guidelines for the management of bone sarcomas
Craig Gerrand, Nick Athanasou, Bernadette Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma
Ian Judson, Michelle Scurr, Kate Gardner, et al.
Oncology
|
January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer
Hendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG
Viktor Grünwald, Saskia Litière, Robin Young, et al.
Clinical Sarcoma Research
|
November 28, 2013
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature
Han Hsi Wong, Helen M Hatcher, Charlotte Benson, et al.
Circulation
|
November 7, 2012
Characterization of cardiac sarcoma with 2- and 3-dimensional echocardiography, myocardial contrast echocardiography and cardiac magnetic resonance imaging
Sanjeev Bhattacharyya, Isabelle Roussin, Sanjay Prasad, et al.
Anticancer Research
|
October 28, 2015
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study
Jonathan Noujaim, Khin Thway, Robin L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2008
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?
Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, et al.
Sarcoma
|
July 13, 2016
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas
Joanna Vitfell-Rasmussen, Ian Judson, Akmal Safwat, et al.
Page
of 16